Thiazolidinediones

DBCAT002198Therapeutic categoryA10BG

A group of oral anti-diabetic drugs designed to treat patients with type 2 diabetes. Thiazolidenediones are compounds that act as agonists of the peroxisome proliferator-activated receptor-gamma increasing tissues sensibility (muscle, adiposity tissue, and liver) to... A DrugBank category of 8 drugs. 3 of them are approved.

ATC classification: A — ALIMENTARY TRACT AND METABOLISM
A10 — DRUGS USED IN DIABETES
A10B — BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BG — Thiazolidinediones
Part of: Blood Glucose Lowering Agents
Also known as: Antidiabetic Agents (Thiazolidinedione) · Glitazones · PPST agonists · Thiazolidene derivatives · TZDs
Drugs: Balaglitazone
Ciglitazone
Lobeglitazone
Netoglitazone
Pioglitazone
Rivoglitazone
Rosiglitazone
Troglitazone

What you can answer from here — as of January 31, 2021

8DrugsEach linked to its full drug card

Listed above

11Drug targetsEvery drug–target pair in the class, with bond type

1,483Marketed productsAcross the regions we cover, with dosage forms and routes

2Routes of administrationHow the drugs in this class are given

Which targets do Thiazolidinediones share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account